This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Robert J. Schneider
Albert Sabin Professor of Molecular Pathogenesis at NYU School of Medicine, Alexandria Center for Life Sciences


I am the Albert Sabin Professor of Molecular Pathogenesis, Associate Dean for NYU Technology Ventures and Partnerships (the technology, commercialization and therapeutics discovery office of NYU), and Co-director of the Breast Cancer Research Program at NYU School of Medicine. Our research is directed to three major areas: (1) translational regulation of advanced breast cancers and the development of new treatment strategies and therapeutics for advanced cancers; (2) translational regulation of the immune response and applications in development of immune-oncology therapeutics; (3) and regulation of adult tissue stem cells and tissue regeneration controlled by targeted mRNA decay and translational regulation.

Agenda Sessions

  • Endless Frontier Labs – A model for success

    On Demand